WebHydroxyurea is an antimetabolite used to treat sickle cell anemia crisis. Brand Names. Droxia, Hydrea, Siklos. Generic Name. Hydroxyurea. DrugBank Accession Number. DB01005. Background. An antineoplastic agent that inhibits DNA synthesis through the inhibition of ribonucleoside diphosphate reductase. WebHydroxyurea mechanism of action. Hydroxyurea’s precise mechanism of action is not known. However, various studies support the hypothesis that hydroxyurea therapy causes an immediate inhibition of DNA synthesis by acting as a ribonucleotide reductase inhibitor. It appears not to interfere with the synthesis of ribonucleic acid (RNA) or protein.
Mechanisms of Hydroxyurea-Induced Cellular Senescence: An
WebHydroxyurea selectively inhibits ribonucleoside diphosphate reductase, an enzyme required to convert ribonucleoside diphosphates into deoxyribonucleoside diphosphates, thereby … WebOct 7, 2024 · Hydroxyurea, an agent now commonly used to decrease the number of vaso-occlusive pain crises in patients with sickle cell disease, interferes with DNA synthesis, … curly womens haircut
CLINICAL PHARMACOLOGY Mechanism of Action - Food and …
WebDNA synthesis inhibitors are a group of antibiotics that target the synthesis of DNA in bacteria and other organisms. Metronidazole, a 5-nitroimidazole, prevents the synthesis of nucleic acids, which are the building blocks of DNA, and is effective against many bacteria and protozoans. Metronidazole and related 5-nitroimidazoles are relatively ... WebCOH29, a novel antimetabolite drug developed at City of Hope Cancer Center, has anticancer activity that stems primarily from the inhibition of human ribonucleotide reductase (RNR). This key enzyme in deoxyribonucleotide biosynthesis is the target of WebHydroxyurea: Hydroxyurea is an inhibitor of ribonucleotide reductase and DNA synthesis. It is preferred to busulfan because of its more favorable safety profile. Interferon alpha: Interferon alpha has antiproliferative, immunomodulatory, antiangiogenic and oncogene regulatory properties. Imatinib mesylate (Glevec) curly wool coat